Bill > HR2452

Introduced Session

To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information. This bill amends the Federal Food, Drug, and Cosmetic Act to revise the requirements for health care economic information that is provided to entities selecting drugs for coverage or reimbursement, such as formularies. The information must include a conspicuous and prominent statement describing the differences between the information and the labeling approved for the drug. "Health care economic information" is an analysis that describes the economic consequences of the use of a drug. Such an analysis is no longer required to compare the use of the drug to another intervention or no intervention. An analysis that relates only to an indication for which the drug is not approved is not health care economic information.

Committee Categories

Billy Long (R)*,  Michael Burgess (R),  Kurt Schrader (D), 

Referred to the Subcommittee on Health. (on 05/22/2015)

Official Document